AMANDA RODRIGUEZ: Open Payments
NPI 1346958493 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 46 payments from 11 companies in 2025. Trend: 2023 $855 · 2024 $1,182 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $384 |
| Sumitomo Pharma America, Inc. | 11 | $208 |
| GlaxoSmithKline, LLC. | 8 | $192 |
| Novo Nordisk Inc | 4 | $74 |
| Lilly USA, LLC | 3 | $64 |
| PFIZER INC. | 2 | $43 |
| Exact Sciences Corporation | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: BREZTRI, GEMTESA, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, MOUNJARO, Ozempic, FARXIGA.
Industry payments across FL — which companies pay providers there.
